• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.荷兰苯丙酮尿症患者产前和产后生长发育受损。国家苯丙酮尿症指导委员会。
Arch Dis Child. 1994 Aug;71(2):114-8. doi: 10.1136/adc.71.2.114.
2
Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.苯丙酮尿症患者生长发育受损与饮食治疗的严格程度相关吗?荷兰全国苯丙酮尿症指导委员会。
Acta Paediatr. 1997 Aug;86(8):816-8. doi: 10.1111/j.1651-2227.1997.tb08603.x.
3
Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.苯丙酮尿症患儿的体格生长:II. 苯丙酮尿症协作研究中接受治疗儿童从出生至4岁的生长情况
Pediatrics. 1979 May;63(5):700-7.
4
Growth and skeletal maturation in children with phenylketonuria.苯丙酮尿症患儿的生长与骨骼成熟
Acta Paediatr. 1994 May;83(5):534-41. doi: 10.1111/j.1651-2227.1994.tb13075.x.
5
Physical growth in phenylketonuria: I. A retrospective study.苯丙酮尿症患者的身体发育:I. 一项回顾性研究。
Pediatrics. 1979 May;63(5):694-9.
6
Physical growth of children treated for phenylketonuria.接受苯丙酮尿症治疗儿童的身体发育。
Ann Hum Biol. 1991 Jul-Aug;18(4):357-68. doi: 10.1080/03014469100001662.
7
[20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].[荷兰为期20年的苯丙酮尿症全国筛查。全国苯丙酮尿症指导委员会]
Ned Tijdschr Geneeskd. 1995 Nov 11;139(45):2302-5.
8
Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.苯丙酮尿症患者饮食治疗的体格发育:回顾性研究。
Mol Genet Metab. 2011 Dec;104(4):480-4. doi: 10.1016/j.ymgme.2011.08.002. Epub 2011 Aug 10.
9
The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.荷兰苯丙酮尿症婴儿的总蛋白、天然蛋白和蛋白质替代品摄入量以及身高和头围的增长情况
J Inherit Metab Dis. 2005;28(6):845-54. doi: 10.1007/s10545-005-0122-x.
10
Growth parameters in newborns with hyperphenylalaninaemia.高苯丙氨酸血症新生儿的生长参数
Paediatr Perinat Epidemiol. 2002 Jul;16(3):274-7. doi: 10.1046/j.1365-3016.2002.00423.x.

引用本文的文献

1
Phenotypic study of humanized mice carrying the PAH deep intronic variant c.1199+502A>T.携带PAH基因内含子深处变异c.1199+502A>T的人源化小鼠的表型研究。
Orphanet J Rare Dis. 2025 May 26;20(1):254. doi: 10.1186/s13023-025-03800-6.
2
Evaluating Therapy and Growth in Children with Phenylketonuria: A Retrospective Longitudinal Study from Two Romanian Centers.评估苯丙酮尿症患儿的治疗和生长情况:来自罗马尼亚两个中心的回顾性纵向研究。
Medicina (Kaunas). 2024 Jul 22;60(7):1185. doi: 10.3390/medicina60071185.
3
Allelic phenotype prediction of phenylketonuria based on the machine learning method.基于机器学习方法的苯丙酮尿症等位基因表型预测。
Hum Genomics. 2023 Mar 31;17(1):34. doi: 10.1186/s40246-023-00481-9.
4
The BMI Z-Score and Protein Energy Ratio in Early- and Late-Diagnosed PKU Patients from a Single Reference Center in Mexico.墨西哥单一参考中心的早诊和晚诊苯丙酮尿症患者的 BMI Z 评分和蛋白质能量比。
Nutrients. 2023 Feb 14;15(4):957. doi: 10.3390/nu15040957.
5
Glycomacropeptide in PKU-Does It Live Up to Its Potential?苯丙酮尿症患者的甘氨酰-酪氨酸肽:是否名副其实?
Nutrients. 2022 Feb 14;14(4):807. doi: 10.3390/nu14040807.
6
Phenylketonuria.苯丙酮尿症。
Nat Rev Dis Primers. 2021 May 20;7(1):36. doi: 10.1038/s41572-021-00267-0.
7
Assessment of Anthropometric Indices in Patients with Phenylketonuria.苯丙酮尿症患者人体测量指标评估
Iran J Child Neurol. 2020 Spring;14(2):27-39.
8
Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis.苯丙酮尿症的长期生长:系统评价和荟萃分析。
Nutrients. 2019 Sep 3;11(9):2070. doi: 10.3390/nu11092070.
9
Growth, Protein and Energy Intake in Children with PKU Taking a Weaning Protein Substitute in the First Two Years of Life: A Case-Control Study.在生命的头两年中使用断奶蛋白质替代品的苯丙酮尿症儿童的生长、蛋白质和能量摄入:病例对照研究。
Nutrients. 2019 Mar 5;11(3):552. doi: 10.3390/nu11030552.
10
Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study.单中心横断面研究中低蛋白饮食下苯丙酮尿症患者的正常生长
JIMD Rep. 2019;43:1-6. doi: 10.1007/8904_2018_92. Epub 2018 Feb 25.

本文引用的文献

1
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.母体苯丙酮尿症和高苯丙氨酸血症。未经治疗和经治疗妊娠结局的国际调查。
N Engl J Med. 1980 Nov 20;303(21):1202-8. doi: 10.1056/NEJM198011203032104.
2
Excess weight among children with phenylketonuria.
J Am Coll Nutr. 1982;1(3):293-303. doi: 10.1080/07315724.1982.10718998.
3
Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
Enzyme. 1982;28(4):404-7. doi: 10.1159/000459132.
4
Phenylalanine deficiency syndrome.苯丙氨酸缺乏综合征
J Pediatr. 1966 Aug;69(2):246-9. doi: 10.1016/s0022-3476(66)80327-x.
5
Head circumference from birth to eighteen years. Practical composite international and interracial graphs.从出生到18岁的头围。实用的综合国际和跨种族图表。
Pediatrics. 1968 Jan;41(1):106-14.
6
[Intrauterine growth and intrauterine growth curves].
Maandschr Kindergeneeskd. 1969 Dec;37(7):209-25.
7
Adequacy of low-phenylalanine diet.低苯丙氨酸饮食的充足性。
Am J Dis Child. 1967 May;113(5):522-3. doi: 10.1001/archpedi.1967.02090200054002.
8
Natural history of phenylketonuria and influence of early treatment.苯丙酮尿症的自然病史及早期治疗的影响
Lancet. 1974 Sep 7;2(7880):540-4. doi: 10.1016/s0140-6736(74)91873-x.
9
Birthweights in children with phenylketonuria and in their siblings.
Lancet. 1972 Apr 15;1(7755):809-13. doi: 10.1016/s0140-6736(72)90797-0.
10
[10 years' national screening study of the incidence of phenylketonuria in the Netherlands; 3d report of the National Advisory Phenylketonuria Commission].[荷兰苯丙酮尿症发病率的十年全国筛查研究;全国苯丙酮尿症咨询委员会第三次报告]
Ned Tijdschr Geneeskd. 1985 Jan 12;129(2):74-6.

荷兰苯丙酮尿症患者产前和产后生长发育受损。国家苯丙酮尿症指导委员会。

Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.

作者信息

Verkerk P H, van Spronsen F J, Smit G P, Sengers R C

机构信息

TNO Institute of Preventive Health Care, Leiden, The Netherlands.

出版信息

Arch Dis Child. 1994 Aug;71(2):114-8. doi: 10.1136/adc.71.2.114.

DOI:10.1136/adc.71.2.114
PMID:7944529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1029938/
Abstract

OBJECTIVE

To assess whether physical growth is affected in early treated Dutch patients with phenylketonuria (PKU).

METHODS

The birth weights of all 137 early detected patients with PKU born in the period from 1974 to 1988 in the Netherlands were compared with reference values. Height, head circumference, and weight were measured at the age at which treatment started (commonly about 2-3 weeks), at 6 months of age, and yearly from the child's first birthday up to the age of 10 years. These measurements were compared with reference values.

RESULTS

The adjusted birth weight in patients with PKU was 141 g (95% confidence interval (CI) 66 to 216 g) less than Dutch reference values by Kloosterman and 103 g (95% CI 9 to 196 g) less compared with the birth weight of another reference group. At the age at which treatment started, z scores of patients for height by age were -0.23 (95% CI -0.44 to -0.02) and z scores for head circumference by the age were -0.25 (95% CI -0.44 to -0.06). From the age at which treatment started up to the age of 3 years z scores for height by age further decreased to -0.74 (95% confidence interval -0.93 to -0.56), after which no additional decrease occurred. In contrast, z scores for head circumference increased from -0.25 at the first visit to 0.08 (95% CI -0.14 to 0.30) at the age of 1 year, after which they remained close to zero. Weight by height was close to the expected centiles for all ages.

CONCLUSION

Patients with PKU are growth retarded at birth and have smaller head circumferences than the normal population. In Dutch patients further growth retardation occurs in the first three years of life.

摘要

目的

评估早期接受治疗的荷兰苯丙酮尿症(PKU)患者的身体生长是否受到影响。

方法

将1974年至1988年期间在荷兰出生的137例早期确诊的PKU患者的出生体重与参考值进行比较。在开始治疗时(通常约2 - 3周)、6个月大时以及从儿童一岁生日到10岁每年测量身高、头围和体重。将这些测量结果与参考值进行比较。

结果

PKU患者的校正出生体重比Kloosterman的荷兰参考值低141克(95%置信区间(CI)66至216克),与另一个参考组的出生体重相比低103克(95% CI 9至196克)。在开始治疗时,患者年龄别身高的z值为 -0.23(95% CI -0.44至 -0.02),年龄布头围的z值为 -0.25(95% CI -0.44至 -0.06)。从开始治疗到3岁,年龄别身高的z值进一步降至 -0.74(95%置信区间 -0.93至 -0.56),此后不再进一步下降。相比之下,头围的z值从首次就诊时的 -0.25增加到1岁时的0.08(95% CI -0.14至0.30),此后一直接近零。身高别体重在所有年龄段都接近预期百分位数。

结论

PKU患者出生时生长发育迟缓,头围比正常人群小。在荷兰患者中,生命的头三年会出现进一步的生长发育迟缓。